Solventum Corporation logo SOLV - Solventum Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 7
HOLD 3
SELL 1
STRONG
SELL 0
| PRICE TARGET: $84.67 DETAILS
HIGH: $100.00
LOW: $43.00
MEDIAN: $91.00
CONSENSUS: $84.67
UPSIDE: 9.92%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Strong
Trading 44.9% below fair value
Current Price $77.03
Bear Case $111.84 45.2% upside ($111.84 - $77.03) / $77.03 = 45.2% $10.24 × 12x P/E
Fair Value $139.81 81.5% upside ($139.81 - $77.03) / $77.03 = 81.5% $10.24 × 15x P/E
Bull Case $167.77 117.8% upside ($167.77 - $77.03) / $77.03 = 117.8% $10.24 × 18x P/E

Adjust Assumptions

15.0x
10.24$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 7.5x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $84.67 from 11 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $139.81 per share.

Warnings

ℹ Wall Street's average price target is $84.67 (from 11 analysts). Our estimate is 81% above the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples